AURIZON 3H (UK) LTD
Company number 12836453 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
AURIZON 3H (UK) LTD - Analysis Report
Company Number: 12836453
Analysis Date: 2025-07-20 12:05 UTC
Financial Health Assessment of Aurizon 3H (UK) Ltd
1. Financial Health Score: A
Explanation: Aurizon 3H (UK) Ltd demonstrates robust financial stability with a strong equity base, healthy liquidity, and minimal short-term liabilities. The company's balance sheet reflects a solid financial constitution typical of a holding company structure, with no signs of distress or financial strain.
2. Key Vital Signs
| Vital Sign | Value (2024) | Interpretation |
|---|---|---|
| Shareholders’ Funds | £29,818,852 | Strong net equity indicating solid capital backing. |
| Fixed Assets (Investments) | £29,340,496 | Substantial long-term investments, core asset base. |
| Current Assets | £489,816 | Good level of liquid and short-term assets on hand. |
| Cash Balance | £477,629 | Very healthy cash reserves, indicating excellent liquidity. |
| Current Liabilities | £11,460 | Low short-term liabilities, manageable and well-covered. |
| Net Current Assets | £478,356 | Strong working capital, indicating smooth operational cash flow. |
| Profit & Loss Reserve | £420,671 | Positive retained earnings, reflecting accumulated profits. |
3. Symptoms Analysis
Healthy Cash Flow (“Pulse”): The company maintains a very high cash balance relative to its current liabilities, demonstrating a "healthy pulse" with no liquidity concerns. This reduces risk of short-term financial distress.
Strong Capital Structure (“Skeleton”): The substantial shareholders’ funds and fixed assets (investments in subsidiaries) form a sturdy “skeleton” supporting the company’s financial health. This is typical for a holding company, indicating strong backing from parent and group entities.
Minimal Short-Term Debt (“No Congestion”): Current liabilities are minimal and stable year-on-year, suggesting good management of payables and no signs of financial “congestion” or bottlenecks.
Stable Equity Position (“Healthy Organ Function”): The company’s equity remains steady and strong, serving as a “heart” pumping financial stability through the business.
No Employees: The absence of employees suggests the company operates primarily as a holding entity, which simplifies its financial operations and risks.
No Revenue or Profit & Loss Statement Filed: Filing under small company exemptions means income and expense details are unavailable, but the balance sheet suggests no troubling “symptoms” like declining equity or rising liabilities.
4. Diagnosis
Aurizon 3H (UK) Ltd is in excellent financial health. The company's balance sheet reveals a well-capitalized holding company with substantial investments in group undertakings, a very strong cash position, and limited current liabilities. The stable net current assets and shareholder funds reflect a business free from liquidity or solvency distress.
The “symptoms” of financial distress such as high leverage, poor liquidity, or negative working capital are absent. The company’s financial “vital signs” are stable and robust, indicating an absence of financial “ailments.”
5. Prognosis
Given the current financial indicators and the nature of the business as a holding company, the future financial outlook is positive. The company’s strong capital base and liquidity position provide a solid foundation for ongoing operations and support of subsidiaries. Unless there are external economic shocks or strategic missteps at the group level, Aurizon 3H (UK) Ltd is expected to maintain its financial wellness.
6. Recommendations
Maintain Cash Reserves: Continue prudent cash management to preserve liquidity and flexibility.
Monitor Investments for Impairment: Regularly review subsidiary investments for signs of impairment to ensure asset values remain realistic and do not erode shareholder funds.
Review Working Capital Management: Although current liabilities are low, periodic review ensures that payables and receivables remain well managed and there are no emerging liquidity risks.
Regular Financial Reviews: Even though the company benefits from small company reporting exemptions, consider preparing more detailed internal financial analyses to detect early “symptoms” of financial changes.
Governance and Compliance: Maintain strong governance practices, especially as a holding company with international links, to ensure compliance with UK regulations and mitigate operational risks.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.